ALK-Abelló A/S

alk

ALK-Abelló A/S is an international pharmaceutical company devoted to improve the lives of people with allergies by developing pharmaceuticals products that target the cause of allergy.

ALK-Abelló A/S is the world leader in allergy vaccination (immunotherapy) – a unique treatment including a protective immune response that reduces and potentially halts the allergic reaction.

For further information: www.alk.net

Lundbeckfonden

News

Seminal cancer research secures young professor Research Prize for Young Scientists
7. November 2017
The Lundbeck Foundation honours brilliant new research talents
7. November 2017
Five eminent young scientists are the Lundbeck Foundation’s new Fellows
6. November 2017